JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS
 QUICK SEARCH:   [advanced]


     


First published online July 17, 2009
J Nucl Med 2009, doi:10.2967/jnumed.109.062646
© 2009 by Society of Nuclear Medicine
This Article
Right arrow Full Text (Publish Ahead of Print[PDF])
Right arrow All Versions of this Article:
jnumed.109.062646v1
50/8/1288    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fommei, E.
Right arrow Articles by Marzullo, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fommei, E.
Right arrow Articles by Marzullo, P.


Single-Shot Cardiorenal Scintigraphy with 99mTc-Tetrofosmin: A Dynamic Characterization at Rest and During Adenosine Infusion

Enza Fommei 1*, Laura Bruselli 2, Andrea Ripoli 3, Alessia Gimelli 3, Sergio Ghione 3, Assuero Giorgetti 3, Annette Kush 3, Irene D'Aragona Tagliavia 3, Claudio Passino 3, and Paolo Marzullo 3

1 "Gabriele Monasterio" Foundation, CNR Institute of Clinical Physiology, Pisa, Italy; Department of Internal Medicine, University of Pisa, Pisa, Italy
2 Department of Nuclear Medicine, University of Pisa, Pisa, Italy
3 "Gabriele Monasterio" Foundation, CNR Institute of Clinical Physiology, Pisa, Italy

* To whom correspondence should be addressed. E-mail: fommei{at}ifc.cnr.it.


   Abstract

Renal function is known to be a strong predictor of cardiovascular prognosis, and cardiorenal disease is increasingly investigated in medical research. In this study, we tested the hypothesis that a single combined cardiorenal scintigraphy examination with the perfusion tracer 99mTc-tetrofosmin is feasible and may allow the simultaneous investigation of cardiac and renal pathology in cardiovascular patients. Methods: Thirty patients scheduled for dual-day gated SPECT also gave their informed consent for a renal acquisition after a single injection of 370 MBq of 99mTc-tetrofosmin, at rest (30 patients) or with adenosine (21 patients), and to undergo an additional standard renal study with the glomerular tracer 99mTc-diethylenetriaminepentaacetic acid (DTPA) (74 MBq) after 1 wk (24 patients). Kidney images and renograms were obtained. Renal uptake index, expressed as the percentage ratio of kidney counts cumulated over the second minute after injection to the administered dose, was calculated as a functional renal parameter. Time to peak activity and separate kidney percentage uptake (as the percentage contribution of each kidney to total renal uptake) were also calculated. Results: Compared with 99mTc-DTPA, 99mTc-tetrofosmin provided better-quality kidney images, with a higher uptake index (13.17% ± 4.76% vs. 8.33% ± 2.45%, P < 0.001) and with comparable separate kidney percentage uptake and times to peak activity. 99mTc-tetrofosmin uptake index was significantly lower in the patients who were more compromised according to renal and cardiovascular functional parameters, and correlated with 99mTc-DTPA uptake index (r = 0.77, P < 0.001), serum creatinine (r = 0.59, P < 0.005), log brain natriuretic peptide N-terminal levels (r = -0.65, P < 0.005), myocardial and carotid intima-media wall thickness (for both, r = -0.61, P < 0.005), and the Doppler index of renal vascular resistance (r = -0.60, P < 0.005). In the 21 patients who underwent the provocative test, adenosine induced a significant decrease in renal 99mTc-tetrofosmin uptake index (from 14.12% ± 4.50% to 11.81% ± 3.33%, P < 0.005) suggesting a decrement in renal perfusion or function. Conclusion: 99mTc-tetrofosmin cardiorenal scintigraphy is feasible at low cost as a single-shot study and may allow both the evaluation of renal morphology and renograms during a cardiac study and the calculation of renal functional parameters.

Key Words: cardiorenal disease, myocardial scintigraphy, renal scintigraphy







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2009 by the Society of Nuclear Medicine.